Basit öğe kaydını göster

dc.contributor.authorKant A.
dc.contributor.authorÖztürk S.
dc.contributor.authorArslan M.
dc.contributor.authorErtunç B.
dc.contributor.authorÇomoğlu Ş.
dc.contributor.authorKarakoç H.N.
dc.contributor.authorYılmaz G.
dc.date.accessioned2024-03-12T19:35:36Z
dc.date.available2024-03-12T19:35:36Z
dc.date.issued2021
dc.identifier.issn03936384
dc.identifier.urihttps://doi.org/10.19193/0393-6384_2021_5_394
dc.identifier.urihttps://hdl.handle.net/20.500.12450/2951
dc.description.abstractBackground: In SARS-COV-2 disease, anosmia and dysgeusia are symptoms that are usually detected together. In our study, it was aimed to investigate the impairments in the sense of smell and taste in our COVID-19 patients and to determine the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of the parameters accompanying this impairment. Methods: The study was conducted retrospectively in patients with positive COVID-19 rtRT-PCR test, whose complaints of smell-taste dysfunction were questioned in 6 centers. Result: 8238 patients questioned for the impaired sense of smell and taste were included in our study. 1756 (21.3%) patients had smell-taste dysfunction. Smell dysfunction started 2.9±2.3 days after the onset of COVID-19 specific symptoms and continued for 9.4±2.7 days. There was a positive correlation between the disturbance of smell and taste and the complaints of fever, sore throat, myalgia, weakness, headache, and negative correlation the complaints of cough. 218 (12.4%) of the patients with smell-taste dysfunction stated that this complaint negatively affected their quality of life. Conclusion: Smell-taste dysfunction is more common, especially with the symptoms of upper respiratory tract infection of COVID-19, and has a positive correlation with fever, sore throat, myalgia, weakness, and headache, affects the quality of life of patients and improves in about 10-14 days. © 2021 A. CARBONE Editore. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherA. CARBONE Editoreen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectSmell dysfunctionen_US
dc.subjectTaste dysfunctionen_US
dc.subjectalanine aminotransferaseen_US
dc.subjectaspartate aminotransferaseen_US
dc.subjectC reactive proteinen_US
dc.subjectlactate dehydrogenaseen_US
dc.subjectadulten_US
dc.subjectalanine aminotransferase blood levelen_US
dc.subjectanalytical parametersen_US
dc.subjectanosmiaen_US
dc.subjectArticleen_US
dc.subjectaspartate aminotransferase blood levelen_US
dc.subjectclinical featureen_US
dc.subjectconsciousness disorderen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectcorrelational studyen_US
dc.subjectcoughingen_US
dc.subjectdementiaen_US
dc.subjectdemographyen_US
dc.subjectdescriptive researchen_US
dc.subjectdisease severityen_US
dc.subjectdyspneaen_US
dc.subjectfemaleen_US
dc.subjectfeveren_US
dc.subjectheadacheen_US
dc.subjecthospital dischargeen_US
dc.subjecthumanen_US
dc.subjectlaboratory testen_US
dc.subjectleukocyteen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectmortalityen_US
dc.subjectmulticenter studyen_US
dc.subjectmyalgiaen_US
dc.subjectnauseaen_US
dc.subjectpredictive valueen_US
dc.subjectquality of lifeen_US
dc.subjectreal time reverse transcription polymerase chain reactionen_US
dc.subjectretrospective studyen_US
dc.subjectsensitivity and specificityen_US
dc.subjectsmelling disorderen_US
dc.subjectsore throaten_US
dc.subjecttaste disorderen_US
dc.subjectTurkey (republic)en_US
dc.subjectvomitingen_US
dc.subjectweaknessen_US
dc.titleSeverity and reversibility of smell-taste dysfunction in COVID-19 patientsen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume37en_US
dc.identifier.issue5en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85115741972en_US
dc.identifier.doi10.19193/0393-6384_2021_5_394
dc.department-tempKant, A., Chest Diseases Department, Trabzon Vakfikebir State Hospital, Trabzon, Turkey, Chest Diseases Department, Trabzon Vakfıkebir State Hospital, Trabzon, Turkey, Trabzon Vakfıkebir Devlet Hastanesi, Cumhuriyet Mah. Gülba-harhatun Cad. No:126-A, Vakfıkebir, Trabzon, 61400, Turkey; Öztürk, S., Department of Infection Diseases and Clinical Microbiology, Health Sciences University, Umraniye Research and Education Hospital, Istanbul, Turkey; Arslan, M., Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Amasya University, Amasya, Turkey; Ertunç, B., Department of Infection Diseases and Clinical Microbiology, Health Sciences University, Umraniye Research and Education Hospital, Istanbul, Turkey; Çomoğlu, Ş., Department of Infection Diseases and Clinical Microbiology, Health Sciences University, Umraniye Research and Education Hospital, Istanbul, Turkey; Karakoç, H.N., Department of Infection Diseases and Clinical Microbiology, Bitlis Tatvan State Hospital, Bitlis, Turkey; Yılmaz, G., Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkeyen_US
dc.authorscopusid8693189500
dc.authorscopusid58375502400
dc.authorscopusid57206479186
dc.authorscopusid54381570500
dc.authorscopusid55674382600
dc.authorscopusid57218303901
dc.authorscopusid14830637700


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster